1. 1450 POINTS
    Fred Adams
    The HSA Expert, Health Revival, Athens, GA
    XGEVA (also known as denosumab) is an FDA-approved prescription medicine used to prevent serious bone problems in patients with bone metastases from solid tumors that is covered under Medicare Part B. An estimated 70% of  Medicare beneficiaries with supplemental coverage pay no out of pocket cost for XGEVA, other than possible costs assocaited with office visit, physician, staff, or administrative charges associated with administering the drug.  For those who do not have complete covered, the drug manufacturer offers assistance, known as First Step. Details can be found at http://www.xgeva.com/xgeva-reimbursement.html.
    Answered on May 15, 2014
  2. 1450 POINTS
    Fred Adams
    The HSA Expert, Health Revival, Athens, GA
    XGEVA (also known as denosumab) is an FDA-approved prescription medicine used to prevent serious bone problems in patients with bone metastases from solid tumors that is covered under Medicare Part B. An estimated 70% of  Medicare beneficiaries with supplemental coverage pay no out of pocket cost for XGEVA, other than possible costs associated with office visit, physician, staff, or administrative charges associated with administering the drug.  For those who do not have complete covered, the drug manufacturer offers assistance, known as First Step. Details can be found at http://www.xgeva.com/xgeva-reimbursement.html.
    Answered on May 15, 2014
  3. Did you find these answers helpful?
    Yes
    No
    Go!

Add Your Answer To This Question

You must be logged in to add your answer.


<< Previous Question
Questions Home
Next Question >>